Steven Cohen's position in Sarepta Therapeutics is currently worth $46.6 Million. That's 0.23% of their equity portfolio (131st largest holding). The first Sarepta Therapeutics trade was made in Q2 2014. Since then Steven Cohen bought shares 22 more times and sold shares on 28 occasions. The stake costed the investor $33.1 Million, netting the investor a gain of 41% so far.